PROGNOSTIC HETEROGENEITY AMONG HIGH RISK MULTIPLE MYELOMA PATIENTS (T(4-14) AND DEL17P) ACCORDING TO ADDITIONAL CYTOGENETIC ABNORMALITIES, THE IFM EXPERIENCE

被引：0
|
作者：
Benjamin, H. [1 ]
Florence, M. [2 ]
Alice, C. [3 ,4 ]
Valerie, L. C. [1 ]
Marie-Lorraine, C. [5 ]
Cyrille, H. [6 ]
Xavier, L. [7 ]
Gerald, M. [8 ]
Lionel, K. [9 ]
Murielle, R. [1 ]
Philippe, R. [10 ]
Catherine, S. [9 ]
Francois, L. [11 ]
Sabine, B. [12 ]
Marie, S. Anne [13 ]
Marc, W. [14 ]
Frederique, O. P. [15 ]
Sylvie, C. [16 ]
Gerard, L. [17 ]
Brrigitte, P. [18 ]
Karim, B. [19 ]
Jean, F. [20 ]
Laurent, V. [21 ]
Laurent, G. [22 ]
Bruno, R. [23 ]
Mamoun, D. [24 ]
Margaret, M. [25 ]
Denis, C. [26 ]
Mohamad, M. [22 ]
Thierry, F. [7 ]
Philippe, M. [27 ]
Michel, A. [28 ]
Jill, C. [29 ,30 ]
Stephane, M. [27 ]
Herve, A. L. [31 ,32 ]
机构：
[1] Hop Purpan, Toulouse, France
[2] UMR S 892, Nantes, France
[3] Hop Rangueil, Unite Genom Myelome, Toulouse, France
[4] Hop Rangueil, INSERM, U1037, CRCT, Toulouse, France
[5] Hop Dijon, Dijon, France
[6] Ctr Univ Nancy Brabois, Nancy, France
[7] CHRU Lille, F-59037 Lille, France
[8] Grp Hosp Haut Leveque, Bordeaux, France
[9] CHU Lyon, Lyon, France
[10] CH Perigueux, Perigueux, France
[11] CH DAX, Dax, France
[12] Hop Avicenne, Paris, France
[13] Inst J Paoli I Calmettes, F-13009 Marseille, France
[14] CH DUNKERQUE, Dunkerque, France
[15] CH Annecy, Annecy, France
[16] CH AIX, Aix En Provence, France
[17] CH AVIGNON, Avignon, France
[18] CH Grenoble, Grenoble, France
[19] AP HP, Paris, France
[20] CH Besancon, Besancon, France
[21] CH Chalon, Chalon Sur Saone, France
[22] CH St Antoine, Paris, France
[23] CH Amiens, Amiens, France
[24] CH Angers, Angers, France
[25] CH Caen, Caen, France
[26] CH DIJON, Dijon, France
[27] CHU Nantes, F-44035 Nantes 01, France
[28] Inst Claudius Regaud, Toulouse, France
[29] CHU Purpan, Unite Genom Myelome, Toulouse, France
[30] CHU Purpan, INSERM, U1037, CRCT, Toulouse, France
[31] CHU Toulouse, Unite Genom Myelome, Toulouse, France
[32] CHU Toulouse, INSERM, U1037, CRCT, Toulouse, France
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1287
引用
收藏
页码：495 / 495
页数：1
相关论文
共 47 条
  • [1] Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience
    Hebraud, Benjamin
    Magrangeas, Florence
    Cleynen, Alice
    Lauwers-Cances, Valerie
    Chretien, Marie-Lorraine
    Hulin, Cyrille
    Leleu, Xavier
    Yon, Edwige
    Marit, Gerald
    Karlin, Lionel
    Roussel, Murielle
    Stoppa, Anne-Marie
    Belhadj, Karim
    Voillat, Laurent
    Garderet, Laurent
    Macro, Margaret
    Caillot, Denis
    Mohty, Mohamad
    Facon, Thierry
    Moreau, Philippe
    Attal, Michel
    Munshi, Nikhil
    Corre, Jill
    Minvielle, Stephane
    Avet-Loiseau, Herve
    BLOOD, 2015, 125 (13) : 2095 - 2100
  • [2] Conventional Cytogenetics and FISH [del13q, del17p, t(11;14), t(4;14)] Findings and Their Relationship with Other Risk Factors in Multiple Myeloma
    Balcik, Ozlem S.
    Albayrak, Murat
    Dagdas, Simten
    Helvaci, Nafiye
    Yokus, Osman
    Ceran, Funda
    Ozet, Gulsum
    Ergocen, Salih
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (04): : 203 - 209
  • [3] Efficacy of selinexor in relapsed/refractory multiple myeloma (RRMM) patients with del17p and other high-risk abnormalities: a retrospective single-center study
    Ehsan, Hamid
    Robinson, Myra
    Voorhees, Peter
    Cassetta, Kristen
    Atrash, Shebli
    Bhutani, Manisha
    Varga, Cindy
    Pineda-Roman, Mauricio
    Friend, Reed
    Paul, Barry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S168 - S169
  • [4] Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)
    Ehsan, Hamid
    Robinson, Myra
    Voorhees, Peter M.
    Cassetta, Kristen
    Borden, Shanice
    Atrash, Shebli
    Bhutani, Manisha
    Varga, Cindy
    Pineda-Roman, Mauricio
    Friend, Reed
    Paul, Barry A.
    LIFE-BASEL, 2024, 14 (03):
  • [5] AN ASSAY FOR SIMULTANEOUS DIAGNOSIS OF T(4;14), T(11;14), T(14;16)/T(14;20), DEL1P, ADD1Q, DEL13Q, DEL17P, MS/MF EXPRESSION CLUSTERS, AND THE SKY-92 HIGH RISK SIGNATURE IN MULTIPLE MYELOMA PATIENTS
    Van Vliet, M.
    Kuiper, R.
    Broijl, A.
    de Knegt, Y.
    Hoos, W.
    de Best, L.
    van Duin, M.
    Van Beers, E.
    Sonneveld, P.
    HAEMATOLOGICA, 2013, 98 : 101 - 101
  • [6] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    HAEMATOLOGICA, 2017, 102 : 107 - 107
  • [7] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji
    BLOOD, 2016, 128 (22)
  • [8] No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades
    Chalopin, Thomas
    Vallet, Nicolas
    Theisen, Olivier
    Ochmann, Marlene
    Tiab, Mourad
    Godmer, Pascal
    Barin, Carole
    Herault, Olivier
    Gyan, Emmanuel
    Le Gouill, Steven
    Avet-Loiseau, Herve
    Benboubker, Lotfi
    Moreau, Philippe
    Touzeau, Cyrille
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (03) : 635 - 638
  • [9] Impact of Chromosomal Abnormalities Del(13), T(4;14), and Del(17p) and Prior Treatment on Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Treated with Lenalidomide.
    Loiseau, Herve Avet
    Soulier, Jean
    Fermand, Jean-Paul
    Facon, Thierry
    Attal, Michel
    Harousseau, Jean-Luc
    Belhadj, Karim
    Hulin, Cyril
    Garderet, Laurent
    Dorvaux, Veronique
    Moreau, Philippe
    BLOOD, 2008, 112 (11) : 1262 - 1262
  • [10] Long-Term Analysis of the IFM 99 Trials for Myeloma: Cytogenetic Abnormalities [t(4;14), del(17p), 1q gains] Play a Major Role in Defining Long-Term Survival
    Avet-Loiseau, Herve
    Attal, Michel
    Campion, Loic
    Caillot, Denis
    Hulin, Cyrille
    Marit, Gerald
    Stoppa, Anne-Marie
    Voillat, Laurent
    Wetterwald, Marc
    Pegourie, Brigitte
    Voog, Eric
    Tiab, Mourad
    Banos, Anne
    Jaubert, Jerome
    Bouscary, Didier
    Macro, Margaret
    Kolb, Brigitte
    Traulle, Catherine
    Mathiot, Claire
    Magrangeas, Florence
    Minvielle, Stephane
    Facon, Thierry
    Moreau, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1949 - 1952
12345